[1]
|
Albu, D.F., et al. (2016) Borderline Brenner Tumors Associated with Ovarian Cyst-Case Presentation. Romanian Jour-nal of Morphology and Embryology, 57, 893-898.
|
[2]
|
Shevchuk, M.M., et al. (1980) Histogenesis of Brenner Tumors, I: Histology and Ultrastructure. Cancer, 46, 2607-2616.
https://doi.org/10.1002/1097-0142(19801215)46:12<2607::AID-CNCR2820461213>3.0.CO;2-Q
|
[3]
|
Elisabetta, K., et al. (2013) Ovarian Brenner Tumour: A Morphologic and Immunohistochemical Analysis Suggesting an Origin from Fallopian Tube Epithelium. European Journal of Cancer (Oxford, England: 1990), 49, 3839-3849.
https://doi.org/10.1016/j.ejca.2013.08.011
|
[4]
|
Auersperg, N. (2013) Ovarian Surface Epithelium as a Source of Ovarian Cancers: Unwarranted Speculation or Evidence-Based Hypothesis? Gynecologic Oncology, 130, 246-251. https://doi.org/10.1016/j.ygyno.2013.03.021
|
[5]
|
Hagiwara, H., Ohwada, N. and Takata, K. (2004) Cell Biology of Normal and Abnormal Ciliogenesis in the Ciliated Epithelium. International Review of Cytology, 234, 101-141. https://doi.org/10.1016/S0074-7696(04)34003-9
|
[6]
|
Wang, L., Allison, D. and Shukla, P.S. (2020) Amplification of MDM2 and Loss of p16 Expression: Do They Have a Role in Malignant Transformation of Ovarian Brenner Tumor? American Journal of Clinical Pathology, 154, 133-141.
https://doi.org/10.1093/ajcp/aqaa033
|
[7]
|
Kuhn, E., et al. (2013) Ovarian Brenner Tumour: A Morphologic and Immunohistochemical Analysis Suggesting an Origin from Fallopian Tube Epithelium. European Journal of Cancer, 49, 3839-3849.
https://doi.org/10.1016/j.ejca.2013.08.011
|
[8]
|
Roma, A.A. and Masand, R.P. (2014) Ovarian Brenner Tumors and Walthard Nests: A Histologic and Immunohistochemical Study. Human Pathology, 45, 2417-2422. https://doi.org/10.1016/j.humpath.2014.08.003
|
[9]
|
Seidman, J.D. and Khedmati, F. (2008) Exploring the Histo-genesis of Ovarian Mucinous and Transitional Cell (Brenner) Neoplasms and Their Relationship with Walthard Cell Nests: A Study of 120 Tumors. Archives of Pathology & Laboratory Medicine, 132, 1753-1760. https://doi.org/10.5858/132.11.1753
|
[10]
|
Logani, S., et al. (2003) Immunoprofile of Ovarian Tumors with Putative Transitional Cell (Urothelial) Differentiation Using Novel Urothelial Markers: Histogenetic and Diagnostic Implications. The American Journal of Surgical Pathology, 27, 1434-1441. https://doi.org/10.1097/00000478-200311000-00005
|
[11]
|
Cuatrecasas, M., et al. (2009) Transitional Cell Tumors of the Ovary: A Comparative Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of Brenner Tu-mors and Transitional Cell Carcinomas. The American Journal of Surgical Pathology, 33, 556-567. https://doi.org/10.1097/PAS.0b013e318188b84c
|
[12]
|
Soslow, R.A., et al. (1996) Transitional Cell Neoplasms of the Ovary and Urinary Bladder: A Comparative Immunohistochemical Analysis. International Journal of Gynecological Pathology, 15, 257-265.
https://doi.org/10.1097/00004347-199607000-00011
|
[13]
|
Pfarr, N., et al. (2017) Mutational Profiles of Brenner Tumors Show Distinctive Features Uncoupling Urothelial Carcinomas and Ovarian Carcinoma with Transitional Cell Histology. Genes Chromosomes Cancer, 56, 758-766.
https://doi.org/10.1002/gcc.22480
|
[14]
|
Green, G.E., et al. (2006) Brenner Tumors of the Ovary: Sonographic and Computed Tomographic Imaging Features. Journal of Ultrasound in Medicine, 25, 1245-1251. https://doi.org/10.7863/jum.2006.25.10.1245
|
[15]
|
Woodruff, J.D., et al. (1981) Proliferative and Malignant Bren-ner Tumors. Review of 47 Cases. American Journal of Obstetrics & Gynecology, 141, 118-125. https://doi.org/10.1016/S0002-9378(16)32577-7
|
[16]
|
Balasa, R.W., et al. (1977) The Brenner Tumor: A Clinico-pathologic Review. Obstetrics & Gynecology, 50, 120-128.
|
[17]
|
Jorgensen, E.O., et al. (1970) Clinicopathologic Study of 53 Cases of Brenner’s Tumors of the Ovary. American Journal of Obstetrics & Gynecology, 108, 122-127. https://doi.org/10.1016/0002-9378(70)90215-2
|
[18]
|
Nemeth, A.J. and Patel, S.K. (2003) Meigs Syndrome Revis-ited. Journal of Thoracic Imaging, 18, 100-103.
https://doi.org/10.1097/00005382-200304000-00009
|
[19]
|
Woodruff, R. (2016) The Oxford Textbook of Palliative Medicine, 5th Edition. Journal of Pain & Palliative Care Pharmacotherapy, 30, 335-336. https://doi.org/10.1080/15360288.2016.1246509
|
[20]
|
Gezginç, K., et al. (2012) Malignant Brenner Tumor of the Ovary: Analysis of 13 Cases. International Journal of Clinical Oncology, 17, 324-329. https://doi.org/10.1007/s10147-011-0290-7
|
[21]
|
Nasioudis, D., et al. (2016) Malignant Brenner Tumors of the Ovary: A Population-Based Analysis. Gynecologic Oncology, 142, 44-49. https://doi.org/10.1016/j.ygyno.2016.04.538
|
[22]
|
Ryback, B.J., Ober, W.B. and Bernacki Jr., E.G. (1981) Malig-nant Brenner Tumor of the Ovary. Report of Three Cases. Diagnostic Gynecology and Obstetrics, 3, 61-74.
|
[23]
|
Seldenrijk, C.A., et al. (1986) Malignant Brenner Tumor. A Histologic, Morphometrical, Immunohisto-chemical, and Ultrastructural Study. Cancer, 58, 754-760.
https://doi.org/10.1002/1097-0142(19860801)58:3<754::AID-CNCR2820580324>3.0.CO;2-1
|
[24]
|
Fox, H., Agrawal, K. and Langley, F.A. (1972) The Brenner Tumour of the Ovary. A Clinicopathological Study of 54 Cases. Journal of Obstetrics and Gynaecology of the British Commonwealth, 79, 661-665.
https://doi.org/10.1111/j.1471-0528.1972.tb14220.x
|
[25]
|
Moon, W.J., et al. (2000) Brenner Tumor of the Ovary: CT and MR Findings. Journal of Computer Assisted Tomography, 24, 72-76. https://doi.org/10.1097/00004728-200001000-00015
|
[26]
|
Weinberger, V., et al. (2018) Brenner Tumor of the Ovary-Ultrasound Features and Clinical Management of a Rare Ovarian Tumor Mimicking Ovarian Cancer. Ginekologia Polska, 89, 357-363. https://doi.org/10.5603/GP.a2018.0061
|
[27]
|
Dierickx, I., et al. (2012) Imaging in Gyneco-logical Disease (7): Clinical and Ultrasound Features of Brenner Tumors of the Ovary. Ultrasound in Obstetrics & Gy-necology, 40, 706-713. https://doi.org/10.1002/uog.11149
|
[28]
|
Kondi-Pafiti, A., et al. (2012) Clinicopathological Features and Immunoprofile of 30 Cases of Brenner Ovarian Tumors. Archives of Gynecology and Obstetrics, 285, 1699-1702. https://doi.org/10.1007/s00404-011-2182-5
|
[29]
|
Takeuchi, M., et al. (2008) Malignant Brenner Tumor with Transition from Benign To Malignant Components: Computed Tomographic and Magnetic Resonance Imaging Findings with Pathological Correlation. Journal of Computer Assisted Tomography, 32, 553-554. https://doi.org/10.1097/RCT.0b013e3181506643
|
[30]
|
Jung, S.E., et al. (2002) CT and MR Imaging of Ovarian Tumors with Emphasis on Differential Diagnosis. Radiographics, 22, 1305-1325. https://doi.org/10.1148/rg.226025033
|
[31]
|
Imaoka, I., et al. (2006) Developing an MR Imaging Strategy for Diag-nosis of Ovarian Masses. Radiographics, 26, 1431-1448. https://doi.org/10.1148/rg.265045206
|
[32]
|
Bristow, R.E. and Montz, F.J. (2001) Leiomyomatosis Peritonealis Disseminata and Ovarian Brenner Tumor Associated with Tamoxi-fen Use. International Journal of Gynecological Cancer, 11, 312-315.
https://doi.org/10.1136/ijgc-00009577-200107000-00010
|
[33]
|
Vemavarapu, L., Alatassi, H. and Moghadamfalahi, M. (2011) Unusual Presentation of Benign Cystic Brenner Tumor with Exuberant Psammomatous Calcifications. Inter-national Journal of Surgical Pathology, 19, 120-122.
https://doi.org/10.1177/1066896910387601
|
[34]
|
Tafe, L.J., et al. (2016) Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutu-ally Exclusive RAS Driver Mutations and MYC Amplification. The American Journal of Pathology, 186, 671-677. https://doi.org/10.1016/j.ajpath.2015.11.008
|
[35]
|
Roth, L.M., Dallenbach-Hellweg, G. and Czernobilsky, B. (1985) Ovarian Brenner Tumors. I. Metaplastic, Proliferating, and of Low Malignant Potential. Cancer, 56, 582-591.
https://doi.org/10.1002/1097-0142(19850801)56:3<582::AID-CNCR2820560327>3.0.CO;2-E
|
[36]
|
Hallgrìmsson, J. and Scully, R.E. (1972) Borderline and Malignant Brenner Tumours of the Ovary. A Report of 15 Cases. Acta Patho-logica et Microbiologica Scandinavica. Supplement, 233, 56-66.
|
[37]
|
Uzan, C., et al. (2012) Management and Prognosis of Borderline Ovarian Brenner Tumors. International Journal of Gynecological Cancer, 22, 1332-1336. https://doi.org/10.1097/IGC.0b013e318267db2f
|
[38]
|
Miles, P.A. and Norris, H.J. (1972) Proliferative and Malig-nant Brenner Tumors of the Ovary. Cancer, 30, 174-186.
https://doi.org/10.1002/1097-0142(197207)30:1<174::AID-CNCR2820300125>3.0.CO;2-D
|
[39]
|
Ogawa, K., Jo-hansson, S.L. and Cohen, S.M. (1999) Immunohistochemical Analysis of Uroplakins, Urothelial Specific Proteins, in Ovarian Brenner Tumors, Normal Tissues, and Benign and Neoplastic Lesions of the Female Genital Tract. The Ameri-can Journal of Pathology, 155, 1047-1050. https://doi.org/10.1016/S0002-9440(10)65206-6
|
[40]
|
Riedel, I., et al. (2001) Brenner Tumors but Not Transitional Cell Carcinomas of the Ovary Show Urothelial Differentiation: Immuno-histochemical Staining of Urothelial Markers, Including Cytokeratins and Uroplakins. Virchows Archiv, 438, 181-191. https://doi.org/10.1007/s004280000315
|
[41]
|
Shevchuk, M.M., Fenoglio, C.M. and Richart, R.M. (1980) Histo-genesis of Brenner Tumors, I: Histology and Ultrastructure. Cancer, 46, 2607-2616.
https://doi.org/10.1002/1097-0142(19801215)46:12<2607::AID-CNCR2820461213>3.0.CO;2-Q
|
[42]
|
Ordóñez, N.G. and Mackay, B. (2000) Brenner Tumor of the Ovary: A Comparative Immunohistochemical and Ultrastructural Study with Transitional Cell Carcinoma of the Bladder. Ultrastructural Pathology, 24, 157-167.
https://doi.org/10.1080/01913120050132895
|
[43]
|
Kuhn, E., et al. (2014) The Pathogenesis of Atypical Prolifera-tive Brenner Tumor: An Immunohistochemical and Molecular Genetic Analysis. Modern Pathology, 27, 231-237. https://doi.org/10.1038/modpathol.2013.142
|
[44]
|
Gymnopoulos, M., Elsliger, M.A. and Vogt, P.K. (2007) Rare Cancer-Specific Mutations in PIK3CA Show Gain of Function. Proceedings of the National Academy of Sciences of the United States of America, 104, 5569-5574.
https://doi.org/10.1073/pnas.0701005104
|
[45]
|
Lo, H.W. and Hung, M.C. (2006) Nuclear EGFR Signalling Net-work in Cancers: Linking EGFR Pathway to Cell Cycle Progression, Nitric Oxide Pathway and Patient Survival. British Journal of Cancer, 94, 184-188.
https://doi.org/10.1038/sj.bjc.6602941
|
[46]
|
Roma, A.A. and Masand, R.P. (2015) Different Staining Patterns of Ovarian Brenner Tumor and the Associated Mucinous Tumor. Annals of Diagnostic Pathology, 19, 29-32. https://doi.org/10.1016/j.anndiagpath.2014.12.002
|
[47]
|
Lin, D.I., et al. (2021) Recurrent Urothelial Carcinoma-Like FGFR3 Genomic Alterations in Malignant Brenner Tumors of the Ovary. Modern Pathology, 34, 983-993. https://doi.org/10.1038/s41379-020-00699-1
|
[48]
|
van Rhijn, B.W., et al. (2002) Frequent FGFR3 Mutations in Urothelial Papilloma. The Journal of Pathology, 198, 245-251. https://doi.org/10.1002/path.1202
|
[49]
|
Gust, K.M., et al. (2013) Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer. Molecular Cancer Therapeutics, 12, 1245-1254. https://doi.org/10.1158/1535-7163.MCT-12-1150
|
[50]
|
Haupt, Y., et al. (1997) Mdm2 Promotes the Rapid Degradation of p53. Nature, 387, 296-299.
https://doi.org/10.1038/387296a0
|
[51]
|
Momand, J., et al. (1992) The mdm-2 Oncogene Product Forms a Complex with the p53 Protein and Inhibits p53-Mediated Transactivation. Cell, 69, 1237-1245. https://doi.org/10.1016/0092-8674(92)90644-R
|
[52]
|
Freedman, D.A. and Levine, A.J. (1998) Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6. Molecular and Cellular Biolo-gy, 18, 7288-7293.
https://doi.org/10.1128/MCB.18.12.7288
|
[53]
|
Grote, D., et al. (2006) Pax 2/8-Regulated Gata 3 Expression Is Necessary for Morphogenesis and Guidance of the Nephric Duct in the Developing Kidney. Development, 133, 53-61. https://doi.org/10.1242/dev.02184
|
[54]
|
Raspollini, M.R., et al. (2011) Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: Clinicopathologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of a Case Series. Human Pathology, 42, 1149-1158.
https://doi.org/10.1016/j.humpath.2010.11.011
|
[55]
|
Gulmann, C., et al. (2013) Immunohistochemical Profile to Distinguish Urothelial from Squamous Differentiation in Carcinomas of Urothelial Tract. Human Pathology, 44, 164-172. https://doi.org/10.1016/j.humpath.2012.05.018
|
[56]
|
Zhao, L., et al. (2013) Is GATA3 Expression Maintained in Regional Metastases? A Study of Paired Primary and Metastatic Urothelial Carcinomas. The American Journal of Surgi-cal Pathology, 37, 1876-1881.
https://doi.org/10.1097/PAS.0b013e31829e2525
|
[57]
|
Higgins, J.P., et al. (2007) Placental S100 (S100P) and GATA3: Markers for Transitional Epithelium and Urothelial Carcinoma Discovered by Complementary DNA Microar-ray. The American Journal of Surgical Pathology, 31, 673-680. https://doi.org/10.1097/01.pas.0000213438.01278.5f
|
[58]
|
Li, Y., et al. (2014) GATA3 in the Urinary Bladder: Suppression of Neoplastic Transformation and Down-Regulation by Androgens. American Journal of Cancer Research, 4, 461-473.
|
[59]
|
Khazaeli Najafabadi, M., et al. (2021) Role of GATA3 in Tumor Diagnosis: A Review. Pathology Research and Practice, 226, Article ID: 153611. https://doi.org/10.1016/j.prp.2021.153611
|
[60]
|
Miettinen, M., et al. (2014) GATA3: A Multispecific but Potentially Useful Marker in Surgical Pathology: A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors. The American Journal of Surgical Pathology, 38, 13-22.
https://doi.org/10.1097/PAS.0b013e3182a0218f
|
[61]
|
Roth, L.M., Gersell, D.J. and Ulbright, T.M. (1993) Ovarian Brenner Tumors and Transitional Cell Carcinoma: Recent Developments. International Journal of Gynecological Pa-thology, 12, 128-133.
https://doi.org/10.1097/00004347-199304000-00007
|
[62]
|
Han, J.H., et al. (2015) Intensive Systemic Chemother-apy Is Effective against Recurrent Malignant Brenner Tumor of the Ovary: An Analysis of 10 Cases within a Single Center. Taiwanese Journal of Obstetrics and Gynecology, 54, 178-182. https://doi.org/10.1016/j.tjog.2014.03.008
|